FDA Scientists Warn Over Safety of Untested Peptide Products
What happened
Food and Drug Administration scientists have raised alarms regarding the sale of certain peptides by compounding pharmacies. These products, which are planned to be allowed under the Trump administration, have not undergone FDA-approved clinical trials to assess their safety or efficacy. A professor from the University of Auckland, Peter Shepherd, expressed concern that politicians are overruling established safety procedures.
From rnz.co.nz
Why it matters
The reports detail a potential regulatory shift concerning drug access and oversight. The lack of proven safety data on these peptides raises questions about the market for unproven medical treatments and the standards governing them.
From rnz.co.nz
Who's involved
- Food and Drug AdministrationGovernment agency raising alarms about product safety and efficacy.
- University of AucklandUniversity providing faculty concerns regarding the lack of safety data.
- Tukaram MundheOfficer who holds the appointed leadership role as Commissioner/Chief of the Food and Drug Administration.
Keep exploring
The entities involved
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
-
University of Auckland
university in Auckland, New Zealand